Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100053257Phase 4Recruiting
Phase 4, randomised trial in None comparing Remimazolam + alfentanil with Propofol + alfentanil (2 arms). Primary endpoints: Anesthesia induction and maintenance success rate and Incidence of adverse events during induction and maintenance of anesthesia. Started Nov 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100053257.